A detailed history of Ameriprise Financial Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ameriprise Financial Inc holds 12,084,392 shares of ABT stock, worth $1.39 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares
12,084,392
Previous 10,675,827 13.19%
Holding current value
$1.39 Billion
Previous $1.11 Billion 24.2%
% of portfolio
0.36%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $141 Million - $166 Million
1,408,565 Added 13.19%
12,084,392 $1.38 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $51.2 Million - $57.2 Million
508,524 Added 5.0%
10,675,827 $1.11 Billion
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $57 Million - $63 Million
520,546 Added 5.4%
10,167,303 $1.16 Billion
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $98.5 Million - $121 Million
-1,091,612 Reduced 10.17%
9,646,757 $1.06 Billion
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $116 Million - $139 Million
-1,212,030 Reduced 10.14%
10,738,369 $1.04 Billion
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $19 Million - $21.2 Million
188,822 Added 1.61%
11,950,399 $1.3 Billion
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $326 Million - $383 Million
-3,363,467 Reduced 22.24%
11,761,577 $1.19 Billion
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $20.1 Million - $23.6 Million
211,241 Added 1.42%
15,125,044 $1.66 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $13.9 Million - $16.1 Million
-143,799 Reduced 0.95%
14,913,803 $1.44 Billion
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $22.3 Million - $27 Million
218,904 Added 1.48%
15,057,602 $1.63 Billion
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $313 Million - $382 Million
-2,746,722 Reduced 15.62%
14,838,698 $1.74 Billion
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $179 Million - $219 Million
1,549,484 Added 9.66%
17,585,420 $2.47 Billion
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $214 Million - $237 Million
1,835,672 Added 12.93%
16,035,936 $1.89 Billion
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $45.5 Million - $53.6 Million
430,055 Added 3.12%
14,200,264 $1.64 Billion
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $31.6 Million - $37.3 Million
-290,779 Reduced 2.07%
13,770,209 $1.65 Billion
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $72.4 Million - $78.9 Million
689,208 Added 5.15%
14,060,988 $1.54 Billion
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $153 Million - $186 Million
1,672,578 Added 14.3%
13,371,780 $1.46 Billion
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $25.2 Million - $32.3 Million
-329,356 Reduced 2.74%
11,699,202 $1.07 Billion
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $102 Million - $149 Million
1,620,355 Added 15.57%
12,028,558 $952 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $126 Million - $140 Million
1,599,909 Added 18.16%
10,408,203 $904 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $11 Million - $11.9 Million
-134,183 Reduced 1.5%
8,808,294 $737 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $273 Million - $318 Million
3,739,337 Added 71.87%
8,942,477 $752 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $53.3 Million - $64.4 Million
-804,272 Reduced 13.39%
5,203,140 $416 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $94.8 Million - $107 Million
-1,446,195 Reduced 19.4%
6,007,412 $435 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $12 Million - $14.4 Million
-196,533 Reduced 2.57%
7,453,607 $673 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $80 Million - $88.3 Million
1,390,313 Added 22.21%
7,650,140 $467 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $47.9 Million - $54.2 Million
-851,797 Reduced 11.98%
6,259,827 $375 Million
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $105 Million - $113 Million
-1,963,611 Reduced 21.64%
7,111,624 $406 Million
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $436 Million - $487 Million
9,075,235
9,075,235 $484 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.